• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.11% Nasdaq Down 0.58%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    22.81 Down 0.35(1.51%) 9:54AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:23.16
    Open:23.16
    Bid:22.61 x 100
    Ask:22.75 x 200
    1y Target Est:34.75
    Beta:-0.25
    Earnings Date:Feb 24 - Mar 2 (Est.)
    Day's Range:22.62 - 23.16
    52wk Range:19.10 - 68.76
    Volume:44,789
    Avg Vol (3m):1,200,930
    Market Cap:648.60M
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 1.51%648.60M
    AZNUp 1.28%90.83B
    MRKDown 0.37%174.53B
    PFEDown 0.89%199.51B

    Key Statistics

    Forward P/E (1 yr):141.90
    P/S (ttm):5.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.92
    Quarterly EPS Est (Dec-14) :0.04
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):-4.94

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback